Age, sexual behavior and human papillomavirus infection in oral cavity and oropharyngeal cancers
Top Cited Papers
Open Access
- 13 November 2003
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 108 (5) , 766-772
- https://doi.org/10.1002/ijc.11633
Abstract
There are few well‐established patient risk factors associated with human papillomavirus (HPV) infection in cancers of the oral cavity and oropharynx. The purpose of this study was to determine if there were significant different risk factors and tumor characteristics between HPV‐positive and HPV‐negative cancer cases. HPV was evaluated in cancer tissue and exfoliated oral cells of 193 oral cavity/oropharynx cancer patients using PCR and direct DNA sequencing. A patient questionnaire collected information about risk factors, sexual practices and medical history. The prevalence of HPV high‐risk (HR) types was 20% in cancer cases. Three types were identified: HPV‐16 (87%), HPV‐18 (3%) and HPV‐33 (11%). Risk factors for HPV‐HR included younger age (≤ 55 years vs. > 55 years; adjusted OR = 3.4; 95% CI = 1.6–7.3) and younger‐age cases who had more lifetime sex partners (adjusted OR = 3.8; 95% CI = 1.4–10.1), practiced oral‐genital sex (adjusted OR = 4.3; 95% CI = 1.8–10.4) or oral‐anal sex (adjusted OR = 19.5; 95% CI = 3.4–113). Compared to HPV‐negative cancers, HPV‐HR cancers were more likely to have a positive HPV‐HR exfoliated oral cytology test (adjusted OR = 7.8; 95% CI = 3.4–18.4), later stage (adjusted OR = 3.0), nodal involvement (adjusted OR = 4.1) and advanced grade (adjusted OR = 3.0). This study shows new evidence that the prevalence of oncogenic mucosal HPV is higher in younger‐age oral cavity/oropharynx cancer cases whose sexual practices are typically associated with sexual transmission of the virus. HPV detection also appears to be an indicator of advanced disease characteristics that may require different clinical treatment for this subset of patients. An exfoliated oral cytology test for HPV was a significant predictor of HR types in the cancers, suggesting that an oral rinse may provide an early biomarker of infected tumors.Keywords
This publication has 29 references indexed in Scilit:
- Human papillomavirus infection as a prognostic factor in carcinomas of the oral cavity and oropharynxInternational Journal of Cancer, 2003
- Human Papillomavirus Infection as a Risk Factor for Squamous-Cell Carcinoma of the Head and NeckNew England Journal of Medicine, 2001
- Human papillomavirus (HPV) DNA in tonsillar cancer: Clinical correlates, risk of relapse, and survivalInternational Journal of Cancer, 2000
- Head and Neck Cancer in CNonsmokers: A Distinct Clinical and Molecular EntityThe Laryngoscope, 1999
- Gapped BLAST and PSI-BLAST: a new generation of protein database search programsNucleic Acids Research, 1997
- Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide PerspectiveJNCI Journal of the National Cancer Institute, 1995
- Human papillomaviruses in 91 oral cancers from indian betel quid chewers—high prevalence and multiplicity of infectionsInternational Journal of Cancer, 1995
- The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCRJournal of General Virology, 1995
- Persistence of Type-Specific Human Papillomavirus Infection among Cytologically Normal WomenThe Journal of Infectious Diseases, 1994
- Human papillomavirus type 16 DNA sequenceVirology, 1985